Moors & Cabot, Inc. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Moors & Cabot, Inc. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$47,458
+14.4%
12,2000.0%0.00%0.0%
Q4 2022$41,480
-63.9%
12,200
-42.3%
0.00%
-66.7%
Q3 2022$115,000
+21.1%
21,1500.0%0.01%
+28.6%
Q2 2022$95,000
-40.3%
21,150
-1.9%
0.01%
-30.0%
Q1 2022$159,000
+14.4%
21,5500.0%0.01%
+11.1%
Q4 2021$139,000
+13.0%
21,550
+1.9%
0.01%
+12.5%
Q3 2021$123,000
-35.9%
21,150
+13.4%
0.01%
-38.5%
Q2 2021$192,000
-3.5%
18,650
-1.6%
0.01%
-13.3%
Q1 2021$199,000
-11.9%
18,950
+28.5%
0.02%
-21.1%
Q4 2020$226,00014,7500.02%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders